Modulation of oral bioavailability of anticancer drugs: from mouse to manJan H.M. Schellens, Jos H. Beijnen, Mirte M. Malingré et al.|European Journal of Pharmaceutical Sciences|2000Cited by 148
Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.Heleen A. Bardelmeijer, Olaf van Tellingen, Maarten T. Huisman et al.|PubMed|2002Cited by 135
Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.Heleen A. Bardelmeijer, Olaf van Tellingen, Jos H. Beijnen et al.|PubMed|2000Cited by 121
Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in miceHeleen A. Bardelmeijer, Olaf van Tellingen, Mariët Ouwehand et al.|Investigational New Drugs|2004Cited by 80
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patientsMirte M. Malingré, Jos H. Beijnen, J. Schellens et al.|British Journal of Cancer|2001Cited by 72